siRNA therapy lowers triglycerides in people with uncommon ailment

.ANALYSIS FEATURE.19 September 2024.

Plozasiran reduced triglyceride amounts by 80% and also lowered the risk of pancreatitis in individuals along with constant chylomicronemia, along with or even without a hereditary medical diagnosis.